Press release from Companies: DanCann Pharma’s strategic partner, Cannassure Therapeutics Ltd., enter exclusive licensing agreement regarding topical medical cannabis products based on Lipidor’s AKVANO® technology

Press release from Companies: DanCann Pharma A/S submits new Application to the Danish Medicine Agency for authorisation to produce cannabis intermediate products

Press release from Companies: DanCann Pharma A/S enter exclusive agreement with Cannassure Therapeutics to be multinational distributor for Scandinavia (Denmark, Norway, Sweden, and Finland)

Press release from Companies: DanCann Pharma A/S: The United Nations’ commission reclassifies cannabis, no longer considered risky narcotic

Press release from Companies: Completion and correction: Interim report Q3 2020 DanCann Pharma A/S (publ)

Press release from Companies: Completion and correction: Interim report Q3 2020 DanCann Pharma A/S (publ)

Press release from Companies: The Interim Report 3rd Quarter 2020 for DanCann Pharma A/S is hereby enclosed

Press release from Companies: The Interim Report 3rd Quarter 2020 for DanCann Pharma A/S is hereby enclosed

Press release from Companies: Today is the first day of trading in DanCann Pharma A/S shares and warrants at Spotlight Stock Market

Press release from Companies: Today is the first day of trading in DanCann Pharma A/S shares and warrants at Spotlight Stock Market

Press release from Companies: Additional lock-up agreements have been signed by Chairman of the board and management

Market Notices: Market Notice 275/20 – DanCann Pharma A/S will be listed on Spotlight Stock Market on November 12, 2020